Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Chemed Inc (CHE)

Chemed Inc (CHE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,721,059
  • Shares Outstanding, K 16,009
  • Annual Sales, $ 1,783 M
  • Annual Income, $ 205,540 K
  • 60-Month Beta 1.10
  • Price/Sales 3.72
  • Price/Cash Flow 27.62
  • Price/Book 9.83

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 4.13
  • Number of Estimates 2
  • High Estimate 4.17
  • Low Estimate 4.09
  • Prior Year 3.35
  • Growth Rate Est. (year over year) +23.28%

Price Performance

See More
Period Period Low Period High Performance
1-Month
393.59 +8.37%
on 10/31/19
429.47 -0.68%
on 11/20/19
+9.02 (+2.16%)
since 10/18/19
3-Month
393.59 +8.37%
on 10/31/19
441.79 -3.45%
on 09/06/19
-11.03 (-2.52%)
since 08/20/19
52-Week
260.03 +64.04%
on 12/21/18
441.79 -3.45%
on 09/06/19
+127.20 (+42.49%)
since 11/20/18

Most Recent Stories

More News
DVA or CHE: Which Is the Better Value Stock Right Now?

DVA vs. CHE: Which Stock Is the Better Value Option?

DVA : 72.50 (+0.12%)
CHE : 426.55 (+1.60%)
Chemed Corporation to Present at the 2019 Credit Suisse Healthcare Conference

Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the 28th Annual Credit Suisse Healthcare Conference on Wednesday, November 13, 2019, at approximately 10:20 a.m. (MST)...

CHE : 426.55 (+1.60%)
Chemed Corporation Declares Quarterly Dividend of 32 Cents

Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 32-cents per share on the Company's capital stock, payable on December 2, 2019, to shareholders...

CHE : 426.55 (+1.60%)
Chemed (CHE) Q3 Earnings Beat Estimates

Chemed (CHE) delivered earnings and revenue surprises of 4.53% and -0.89%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

CHE : 426.55 (+1.60%)
Chemed: 3Q Earnings Snapshot

CINCINNATI (AP) _ Chemed Corp. (CHE) on Tuesday reported third-quarter earnings of $58.9 million.

CHE : 426.55 (+1.60%)
Chemed Reports Third-Quarter 2019 Results

Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial...

CHE : 426.55 (+1.60%)
Healthcare Stock Earnings Slated on Oct 29: HCA, MOH & More

Increasing demands for products and services are likely to have driven earnings for players in the healthcare industry.

MOH : 135.53 (+0.05%)
HCA : 139.76 (+0.68%)
CHE : 426.55 (+1.60%)
AMED : 154.76 (+0.40%)
Here's Why You Should Hold on to Chemed (CHE) Stock Right Now

Investors continue to be optimistic about Chemed's (CHE) performance.

SRDX : 39.94 (+1.91%)
HAE : 120.08 (-0.63%)
OMER : 14.32 (+3.02%)
CHE : 426.55 (+1.60%)
Zacks.com featured highlights include: MDU Resources, Gibraltar Industries, Chemed, Federal Signal and SolarEdge Technologies

Zacks.com featured highlights include: MDU Resources, Gibraltar Industries, Chemed, Federal Signal and SolarEdge Technologies

MDU : 29.28 (+0.21%)
FSS : 32.86 (-0.42%)
CHE : 426.55 (+1.60%)
ROCK : 52.27 (-0.48%)
SEDG : 78.31 (-0.90%)
Buy These 5 Low Leverage Stocks to Stay Afloat in Crisis

With Q3 reporting season knocking on the door, investors are eyeing stocks that exhibited solid earnings growth in the prior quarters. But one should consider the stocks' debt levels before investing.

MDU : 29.28 (+0.21%)
FSS : 32.86 (-0.42%)
CHE : 426.55 (+1.60%)
ROCK : 52.27 (-0.48%)
SEDG : 78.31 (-0.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Good. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade CHE with:

Business Summary

Chemed Corporation is the nation's largest provider of end-of-life hospice care services through its VITAS Healthcare Corporation subsidiary. Chemed also maintains a presence in the residential and commercial repair-and-maintenance industry through two subsidiaries. Roto-Rooter is North America's largest...

See More

Key Turning Points

2nd Resistance Point 435.36
1st Resistance Point 430.96
Last Price 426.55
1st Support Level 420.66
2nd Support Level 414.76

See More

52-Week High 441.79
Last Price 426.55
Fibonacci 61.8% 372.36
Fibonacci 50% 350.91
Fibonacci 38.2% 329.46
52-Week Low 260.03

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar